These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8435989)

  • 41. [Role of the determination of serum fructosamine in the screening of glucose intolerance].
    Ben Rayana MC; Aoun K; Achour A; Zouaghi H
    Ann Biol Clin (Paris); 1994; 52(5):389-90. PubMed ID: 7856941
    [No Abstract]   [Full Text] [Related]  

  • 42. Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control.
    Yamanouchi T; Akanuma Y
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S261-8. PubMed ID: 7859616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. The DECODE-study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic Criteria in Europe.
    Diabetologia; 1999 Jun; 42(6):647-54. PubMed ID: 10382583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of diabetes mellitus and impaired glucose tolerance in factory workers from Transkei, South Africa.
    Erasmus RT; Blanco Blanco E; Okesina AB; Matsha T; Gqweta Z; Mesa JA
    S Afr Med J; 2001 Feb; 91(2):157-60. PubMed ID: 11288399
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
    Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
    Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of nifedipine on glucose tolerance, serum insulin, and serum fructosamine in diabetic and nondiabetic patients.
    Gill JS; Al-Hussary N; Zezulka AV; Pasi KJ; Atkins TW; Beevers DG
    Clin Ther; 1987; 9(3):304-10. PubMed ID: 3300989
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A method of estimation for prevalence of diabetes mellitus from fructosamine levels].
    Hashimoto S; Nagai M; Sakata K; Yanagawa H; Sueta H; Tanaka T; Shirahama S
    Nihon Koshu Eisei Zasshi; 1994 Jan; 41(1):67-73. PubMed ID: 8111098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fructosamine Test-Plus, a modified fructosamine assay evaluated.
    Baker J; Metcalf P; Scragg R; Johnson R
    Clin Chem; 1991 Apr; 37(4):552-6. PubMed ID: 2015670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?
    Shaw JE; Zimmet PZ; de Courten M; Dowse GK; Chitson P; Gareeboo H; Hemraj F; Fareed D; Tuomilehto J; Alberti KG
    Diabetes Care; 1999 Mar; 22(3):399-402. PubMed ID: 10097917
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical usefulness of estimation of serum fructosamine concentration as screening test for gestational diabetes.
    Comtois R; Desjarlais F; Nguyen M; Beauregard H
    Am J Obstet Gynecol; 1989 Mar; 160(3):651-4. PubMed ID: 2929687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin and blood pressure levels are not independently related in Mauritians of Asian Indian, Creole or Chinese origin. The Mauritius Non-communicable Disease Study Group.
    Dowse GK; Collins VR; Alberti KG; Zimmet PZ; Tuomilehto J; Chitson P; Gareeboo H
    J Hypertens; 1993 Mar; 11(3):297-307. PubMed ID: 8387088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diabetes screening after gestational diabetes mellitus: poor performance of fasting plasma glucose.
    Cypryk K; Czupryniak L; Wilczyński J; Lewiński A
    Acta Diabetol; 2004 Mar; 41(1):5-8. PubMed ID: 15057547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Random capillary whole blood glucose test as a screening test for diabetes mellitus in a middle-aged population.
    Qiao Q; Keinänen-Kiukaanniemi S; Rajala U; Uusimäki A; Kivelä SL
    Scand J Clin Lab Invest; 1995 Feb; 55(1):3-8. PubMed ID: 7624734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of glucose tolerance categories in the Korean population according to World Health Organization and American Diabetes Association diagnostic criteria.
    Park KS; Park YJ; Kim SW; Shin CS; Park DJ; Koh JJ; Kim SY; Kim NK; Lee HK
    Korean J Intern Med; 2000 Jan; 15(1):37-41. PubMed ID: 10714090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Fasting or post-challenge blood glucose values for detection of glucose intolerance in screening for metabolic syndrome?].
    Jermendy G; Hidvégi T; Hetyési K; Bíró L
    Orv Hetil; 2002 Sep; 143(39):2247-52. PubMed ID: 12418378
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Determination of postpartum fructosamine for assessment of gestational diabetes--a suitable method?].
    Heyl W; Schröder W; Kitschke HJ
    Zentralbl Gynakol; 1995; 117(5):269-73. PubMed ID: 7793170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detecting diabetes and impaired glucose tolerance in patients with atherosclerotic peripheral arterial disease.
    Green FC; Levison R; Newton DJ; Littleford R; Stonebridge PA; Belch JJ
    Int Angiol; 2012 Apr; 31(2):125-8. PubMed ID: 22466976
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screening for gestational diabetes mellitus in pregnant females.
    Ardawi MS; Nasrat HA; Jamal HS; Al-Sagaaf HM; Mustafa BE
    Saudi Med J; 2000 Feb; 21(2):155-60. PubMed ID: 11533772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma 1,5-anhydroglucitol concentrations are influenced by variations in the renal threshold for glucose.
    Kilpatrick ES; Keevilt BG; Richmond KL; Newland P; Addison GM
    Diabet Med; 1999 Jun; 16(6):496-9. PubMed ID: 10391398
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diabetes mellitus and employment: survey of a New Zealand workforce.
    Baker J; Scragg R; Metcalf P; Dryson E
    Diabet Med; 1993 May; 10(4):359-61. PubMed ID: 8508621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.